A Phase II Study of Docetaxel and Vinorelbine Plus Filgrastim for HER-2 Negative, Stage IV Breast Cancer: SWOG S0102

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-013-2797-2

Related search